ACTIVATION OF 70-KDA S6 KINASE, INDUCED BY THE CYTOKINES INTERLEUKIN-3 AND ERYTHROPOIETIN AND INHIBITED BY RAPAMYCIN, IS NOT AN ABSOLUTE REQUIREMENT FOR CELL-PROLIFERATION

被引:41
作者
CALVO, V
WOOD, M
GJERTSON, C
VIK, T
BIERER, BE
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV PEDIAT ONCOL,BOSTON,MA 02115
[2] HARVARD UNIV,CHILDRENS HOSP,BOSTON,MA 02115
[3] BRIGHAM & WOMENS HOSP,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02115
[4] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA
关键词
PROTEIN KINASES; CYTOKINES; RAPAMYCIN; PROLIFERATION;
D O I
10.1002/eji.1830241115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytokines interleukin (IL)-3 and erythropoietin (EPO) are critical regulators of the proliferation and differentiation of cells of the hematopoietic system, but their intracellular mechanisms of action are not fully understood. Binding of IL-3 to the IL-3 receptor (IL-3R) and binding of EPO to the EPOR both induce changes in intracellular tyrosine and serine/threonine phosphorylation; the phosphorylation of a number of polypeptides appears to be a shared response upon cytokine stimulation. We have previously shown that binding of IL-2 to the IL-2R activates the 70-kDa (p70) 86 kinase, a serine/threonine kinase whose activity is regulated by serine/threonine phosphorylation; the immunosuppressant rapamycin inhibits IL-2-dependent proliferation and IL-2-triggered activation of p70 S6 kinase. We, therefore, sought to examine whether induction of p70 86 kinase activity is a conserved response upon cytokine triggering, and whether this activity is essential for cell proliferation. Proliferation of the IL-3-dependent pro-B cell line Ba/F3 transfected with the EPOR (Ba/F3-EPOR) can be supported by either IL-3 or EPO. In this cell line, both IL-3 and EPO induced p70 86 kinase activity; rapamycin inhibited both the IL-3 and EPO-induced activation of the 70-kDa S6 kinase as well as cellular proliferation. Thus: p70 S6 kinase activation appears to be a common intermediate triggered by the stimulation of IL-3, EPO, and IL-2 receptors. The Friend spleen focus-forming virus gp55 renders the EPOR constitutively active, and confers growth factor independence on cells expressing EPOR. Ba/F3-EPOR cotransfected with gp55 (Ba/F3-EpoRgp55) and the erythroleukemia cell line MEL, which also expresses both the EPOR and gp55, were analyzed. Rapamycin inhibited the activation of p70 S6 kinase in both cell lines. However, rapamycin inhibited proliferation of Ba/F3-EpoRgp55 but not of MEL cells despite inhibition of p70 86 kinase activity in both cells. Thus, p70 86 kinase activation is not an absolute requirement for cell proliferation. These results are discussed in relation to the role of the activation of the 70-kDa 86 kinase activation pathway in the regulation of cell cycle progression.
引用
收藏
页码:2664 / 2671
页数:8
相关论文
共 51 条
[1]   SEQUENCE AND EXPRESSION OF CHICKEN AND MOUSE RSK - HOMOLOGS OF XENOPUS-LAEVIS RIBOSOMAL S6 KINASE [J].
ALCORTA, DA ;
CREWS, CM ;
SWEET, LJ ;
BANKSTON, L ;
JONES, SW ;
ERIKSON, RL .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) :3850-3859
[2]  
ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.bi.59.070190.004031
[3]   INTERLEUKIN-2 AND POLYOMAVIRUS MIDDLE T-ANTIGEN-INDUCED MODIFICATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY IN ACTIVATED LYMPHOCYTES-T [J].
AUGUSTINE, JA ;
SUTOR, SL ;
ABRAHAM, RT .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4431-4440
[4]   S6 KINASE IN QUIESCENT SWISS MOUSE 3T3 CELLS IS ACTIVATED BY PHOSPHORYLATION IN RESPONSE TO SERUM TREATMENT [J].
BALLOU, LM ;
SIEGMANN, M ;
THOMAS, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7154-7158
[5]   FRIEND VIRUS-INDUCED ERYTHROLEUKEMIA AND THE MULTISTAGE NATURE OF CANCER [J].
BENDAVID, Y ;
BERNSTEIN, A .
CELL, 1991, 66 (05) :831-834
[6]  
Bierer B. E., 1993, CURR OPIN HEMATOL, V1, P149
[7]   2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN [J].
BIERER, BE ;
MATTILA, PS ;
STANDAERT, RF ;
HERZENBERG, LA ;
BURAKOFF, SJ ;
CRABTREE, G ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9231-9235
[8]  
BLENIS J, 1991, CELL GROWTH DIFFER, V2, P279
[9]  
BOULAY JL, 1992, J BIOL CHEM, V267, P20525
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3